Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Postmenopause
Interventions
DRUG

Estradiol and Progesterone

3 mg/day intranasal estradiol daily or 1,5 mg/day transdermal estradiol and 200 mg/day vaginal micronized progesterone for 14 days/month

DRUG

Estradiol and Drospirenone

oral estradiol 1mg and drospirenone 2 mg/day

Trial Locations (1)

Unknown

Hospital de Clínicas de Porto Alegre, Porto Alegre

All Listed Sponsors
collaborator

Hospital de Clinicas de Porto Alegre

OTHER

collaborator

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

OTHER_GOV

collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

lead

Denusa Wiltgen

OTHER

NCT01432028 - Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women | Biotech Hunter | Biotech Hunter